Related Experiment Videos

[Effect of proteolytic enzymes on the antimicrobial activity of antibiotics]

Antibiotiki
|June 1, 1975
PubMed

Insights

Chemotrypsin significantly enhances the antimicrobial activity of monomycin against bacteria, including antibiotic-resistant strains. This combination therapy allows for reduced antibiotic dosages, offering a novel approach to combatting infections.

Area of Science:

  • Microbiology
  • Pharmacology

Background:

  • Antibiotic resistance is a growing global health threat.
  • Monomycin is an antibiotic with limitations in efficacy against certain pathogens.
  • Purulent peritonitis involves complex microbial environments.

Observation:

  • Chemotrypsin was investigated for its potential to potentiate monomycin's antimicrobial effects.
  • Studies included laboratory bacterial cultures (Staph. aureus, E. coli, Streptococcus zymogenes) and clinical isolates.
  • The method of two-fold serial dilutions was employed to determine minimum inhibitory concentrations (MIC).

Findings:

  • Chemotrypsin reduced the minimum inhibitory concentration (MIC) and bactericidal concentration of monomycin by 3.2 x 10^2 to 2.6 x 10^5 times.
  • Fibrin in the medium inhibited monomycin's antibacterial effect 4-128 fold.
  • Chemotrypsin's potentiation is attributed to improved antibiotic-microbe contact and increased microbial sensitivity.

Implications:

  • Combining monomycin with chemotripsin allows for lower antibiotic doses.
  • This combination is effective in overcoming antibiotic resistance in pathogenic microbes.
  • Potential for developing new therapeutic strategies against resistant bacterial infections.

Related Concept Videos